SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-15-274909
Filing Date
2015-08-03
Accepted
2015-08-03 16:33:59
Documents
1
Group Members
AGTC PARTNERS L.PAPPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.EDWIN M. KANIA, JR.FLAGSHIP VENTURES 2007 GENERAL PARTNER, LLCFLAGSHIP VENTURES FUND 2007, L.P.FLAGSHIP VENTURES MANAGMENT, INC.NEWCOGEN GROUP, INC.NOUBAR B AFEYAN PH. D.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 4 TO SCHEDULE 13D d23882dsc13da.htm SC 13D/A 225902
  Complete submission text file 0001193125-15-274909.txt   227731
Mailing Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
AGTC ADVISORS FUND LP (Filed by) CIK: 0001131095 (see all company filings)

IRS No.: 522266955
Type: SC 13D/A

Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Subject) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86104 | Film No.: 151022768
SIC: 2835 In Vitro & In Vivo Diagnostic Substances